VXA-CoV2-3.1, COMIRNATY®, VXA-CoV2-3.3 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11 (month) in 4mo
ESTIMATED |
READOUT
A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Aut
Phase 2 · SARS-CoV2, COVID-19 |
VXRT Vaxart, Inc. | VXA-CoV2-3.1, COMIRNATY®, VXA-CoV2-3.3 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|